Recently, Heerma et al. reported that DDX3 is a key regulator of mitochondrial translation and its inhibitor RK-33 enhanced the sensitivity of radiotherapy in breast cancer via blocking mitochondrial translation18. The gene discussed is DDX3X; the disease is breast cancer.